Probucol in the treatment of hyperlipidemias
Feder, D.; Langer, A.L.; Alexandrino, E.; Medeiros, S.; Lotto, M.; Valente, O.
Arquivos Brasileiros de Cardiologia 46(2): 77-80
1986
ISSN/ISBN: 0066-782X PMID: 3827649 Document Number: 280332
Document emailed within 1 workday
Related Documents
Lokshina, L.I.; Tananova, G.V.; Maiorov, V.N.; Baranich, I.I.; Silonova, V.B. 1986: Treatment of ischemic heart disease with probucol Sovetskaia Meditsina 5: 67-69Kouzuma, R.; Tasaki, H.; Komura, T.; Nakashima, Y.; Kuroiwa, A.; Tanimoto, A.; Koide, O. 1995: Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta Artery 21(6): 337-351
Lane, J.T.; Subbaiah, P.V.; Otto, M.E.; Bagdade, J.D. 1991: Lipoprotein composition and HDL particle size distribution in women with non-insulin-dependent diabetes mellitus and the effects of probucol treatment Journal of Laboratory and Clinical Medicine 118(2): 120-128
1993: Diagnosis and treatment of hypercholesterolemia and other and hyperlipidemias in the year 1992. Finnish Associations of Internists, Cardiologists, Heart Diseases, Community Physicians, and the Committee of Industrial Medicine Duodecim; Laaketieteellinen Aikakauskirja 109(6): 481-501
Cox, R.A. 2003: The hyperlipidemias Boletin de la Asociacion Medica de Puerto Rico 95(5): 36-44
Assmann, G.; Schriewer, H. 1980: The diagnosis of hyperlipidemias Therapeutische Umschau. Revue Therapeutique 37(11): 965-972
Hidalgo Vicario, M.I. 1991: Diagnosis of hyperlipidemias Anales Espanoles de Pediatria 35 Suppl 45(4): 12-16
Yagyu, H. 2001: Probucol Nihon Rinsho. Japanese Journal of Clinical Medicine 59 Suppl. 3: 631-636
Schlierf, G.; Kahlke, W. 1972: Therapy of essential hyperlipidemias Minerva Medica 63(14): 853-855
Assmann, G. 1979: Current diagnosis of hyperlipidemias Der Internist 20(11): 559-564
Wolfram, G. 1981: Drug therapy of hyperlipidemias Wiener Medizinische Wochenschrift 131(13-14): 333-338
Mori, S.; Ito, H. 2007: Classification of hyperlipidemias in Japan Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 7): 237-240
Lugo-Somolinos, A.íd.; Sánchez, J.E. 2003: Xanthomas: a marker for hyperlipidemias Boletin de la Asociacion Medica de Puerto Rico 95(4): 12-16
Schoonmaker, F.W.; King, S.B.; Vijay, N.K. 1973: Hyperlipidemias in predicting coronary artherosclerosis by arteriography Rocky Mountain Medical Journal 70(8): 32-36
Berg, K. 1982: The genetics of the hyperlipidemias and coronary artery disease Progress in Clinical and Biological Research 103 Pt B: 111-125
Buxtorf, J.C.; Delplanque, B.; Baudet, M.F.; Beaumont, J.L. 1979: Lipid particles agglutinated in hyperlipidemias with opalescent sera La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 55(3-4): 193-197
Lipovetskiĭ, B.M. 1993: Genealogy and the clinical manifestations of familial hyperlipidemias types IIa and IIb Terapevticheskii Arkhiv 65(12): 34-38
Szczeklik, A. 1974: Differential diagnosis of hyperlipidemias and hypolipidemias in endocrinologic diseases Przeglad Lekarski 31(0): Suppl:79-82
Enjalbert, M.; Lussier-Cacan, S.; DuBreuil-Quidoz, S.; LeLorier, J.; Davignon, J. 1980: Usefulness of probucol in treating primary hypercholesterolemia Canadian Medical Association Journal 123(8): 754-757
Widhalm, K. 1985: Effect of diet on serum lipoproteins in children with various forms of hyperlipidemias Progress in Clinical and Biological Research 188: 145-159